Burning Mouth Syndrome: An Update on Diagnosis and Treatment Methods

References

• Ship JA, Grushka M, et al, Burning mouth syndrome: An update. J Am Dent Assoc 126(7):842-53, July 1995.
   PubMedGoogle Scholar
• Miller IJ Jr., Variation in human fungiform taste bud densities among regions and subjects. Anat Rec 216(4):474-82, December 1986.
   PubMedGoogle Scholar
• Grushka M, Epstein JB, Gorsky M, Burning mouth syndrome. Am Fam Physician 65(4):615-20, Feb. 15, 2002.
   PubMed Web of Science ®Google Scholar
• Merskey H, Bogduk N, (eds), Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms/prepared by the Task Force on Taxonomy of the International Association for the Study of Pain, second ed., Seattle, IASP:742, 1994.
   Google Scholar
• ICD-9 CM http://eicd.com/ accessed June 2, 2006.
   Google Scholar
• Nagler RM, Hershkovich O, Sialochemical and gustatory analysis in patients with oral sensory complaints. J Pain 5(1):56-63, February 2004.
   PubMedGoogle Scholar
• Lamey PJ, Lewis MA, Oral medicine in practice: Burning mouth syndrome. Br Dent J 167:197-200, Sept. 23, 1989.
   PubMed Web of Science ®Google Scholar
• Danhauer SC, Miller CS, et al, Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome. J Orofac Pain 16(4):305-11, Fall 2002.
   PubMedGoogle Scholar
• Bergdahl M, Bergdahl J, Burning mouth syndrome: Prevalence and associated factors. J Oral Pathol Med 28(8):350-4, September 1999.
   PubMed Web of Science ®Google Scholar
• Ben Aryeh H, Gottlieb I, et al, Oral complaints related to menopause. Maturitas 24(3):185-9, July 1996.
   PubMedGoogle Scholar
• Lipton JA, Ship JA, Larach-Robinson D, Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 124(10):115-21, October 1993.
   PubMed Web of Science ®Google Scholar
• Riley JL III, Gilbert GH, Heft MW, Orofacial pain symptom prevalence: Selective sex differences in the elderly? Pain 76(1-2):97-104, May 1998.
   PubMedGoogle Scholar
• Lamey PJ, Hobson RS, Orchardson R, Perception of stimulus size in patients with burning mouth syndrome. J Oral Pathol Med 25(8):420-3, September 1996.
   PubMedGoogle Scholar
• Svensson P, Bjerring P, et al, Sensory and pain thresholds to orofacial argon laser stimulation in patients with chronic burning mouth syndrome. Clin J Pain 9(3):207-15, September 1993.
   PubMedGoogle Scholar
• Jaaskelainen SK, Forssell H, Tenovuo O, Abnormalities of the blink reflex in burning mouth syndrome. Pain 73(3):455-60, December 1997.
   PubMed Web of Science ®Google Scholar
• Gao S, Wang Y, Wang Z, Assessment of trigeminal somatosensory evoked potentials in burning mouth syndrome. Chin J Dent Res 3(1):40-6, May 2000.
   PubMedGoogle Scholar
• Lauria G, Majorana A, et al, Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 115(3):332-7, June 2005.
   PubMed Web of Science ®Google Scholar
• Deems DA, Doty RL, et al, Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 117(5):519-28, May 1991.
   PubMed Web of Science ®Google Scholar
• Femiano F, Gombos F, et al, Burning mouth syndrome (BMS): Evaluation of thyroid and taste. Med Oral Patol Oral Cir Bucal 11(1):E22-5, January 2006.
   Google Scholar
• Hershkovich O, Nagler RM, Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Arch Oral Biol 49(7):515-22, July 2004.
   PubMedGoogle Scholar
• Formaker BK, Frank ME, Taste function in patients with oral burning. Chem Senses 25(5):575-81, October 2000.
   PubMedGoogle Scholar
• Doty RL, Bromley SM, Effects of drugs on olfaction and taste. Otolaryngology Clin North Am 37(6):1229-54, December 2004.
   PubMedGoogle Scholar
• Magnasco LD, Magnasco AJ, Metallic taste associated with tetracycline therapy. Clin Pharm 4:455-6, 1985.
   PubMedGoogle Scholar
• Coulter DM, Eye pain with nifedipine and disturbance of taste with captopril: A mutually controlled study showing a method of postmarketing surveillance. Br Med J 296:1086-8, 1980.
   Google Scholar
• Greenberg AJ, Kane JM, et al, Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321:1489-93, 1989.
   PubMedGoogle Scholar
• Hochberg MC, Auranofin or D-penicilla-mine in treatment of rheumatoid arthritis. Ann Int Med 105:528-35, 1986.
   PubMed Web of Science ®Google Scholar
• Coulter DM, Eye pain with nifedipine and disturbance of taste with captopril: A mutually controlled study showing a method of postmarketing surveillance. Br Med J 296:1086-88, 1988.
   PubMedGoogle Scholar
• Frank ME, Smith DV, Electrogustometry: A simple way to test taste. In: Smell and taste in health and disease, pp. 503-514. Getchell TV, Doty RL, et al, (eds) Raven Press, New York, 1991.
   Google Scholar
• Frankel DH, Mostofi RS, Lorincz AL, Oral Crohn’s disease: Report of two cases in brothers with metallic dysgeusia and a review of the literature. J Am Acad Dermatol 12(2 Pt 1):260-8, February 1985.
   PubMedGoogle Scholar
• Zegarelli DJ, Burning mouth: An analysis of 57 patients. Oral Surg Oral Med Oral Pathol 58(1):34-8, July 1984.
   PubMedGoogle Scholar
• Scala A, Checchi L, et al, Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 14(4):275-91, 2003.
   PubMedGoogle Scholar
• Gorsky M, Silverman S Jr., Chinn H, Burning mouth syndrome: A review of 98 cases. J Oral Med 42(1):7-9, January-March 1987.
   PubMedGoogle Scholar
• Forabosco A, Criscuolo M, et al, Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 73(5):570-4, May 1992.
   PubMedGoogle Scholar
• Basker RM, Sturdee DW, Davenport JC, Patients with burning mouths. A clinical investigation of causative factors, including the climacteric and diabetes. Br Dent J 145(1):9-16, July 4, 1978.
   PubMedGoogle Scholar
• Browning S, Hislop S, et al, The association between burning mouth syndrome and psychosocial disorders. Oral Surg Oral Med Oral Pathol 64(2):171-4, August 1987.
   PubMedGoogle Scholar
• Zilli C, Brooke RI, et al, Screening for psychiatric illness in patients with oral dysesthesia by means of the general health questionnaire—28-item version (GHQ-28) and the irritability, depression and anxiety scale (IDA). Oral Surg Oral Med Oral Pathol 67(4):384-9, April 1989.
   PubMedGoogle Scholar
• Rojo L, Silvestre FJ, et al, Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales. Oral Surg Oral Med Oral Pathol 75(3):308-11, March 1993.
   PubMedGoogle Scholar
• Al Quran FA, Psychological profile in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(3):339-44, March 2004.
   PubMedGoogle Scholar
• Carlson CR, Miller CS, Reid KI, Psychosocial profiles of patients with burning mouth syndrome. J Orofac Pain 14(1):59-64, Winter 2000.
   PubMedGoogle Scholar
• Grushka M, Epstein JB, Gorsky M, Burning mouth syndrome and other oral sensory disorders: A unifying hypothesis. Pain Res Manag 8(3):133-5, 2003.
   PubMedGoogle Scholar
• Bartoshuk LM, Snyder DJ, et al, Taste damage: previously unsuspected consequences. Chem Senses 30 Suppl 1:i218-i9, 2005.
   PubMedGoogle Scholar
• Forssell H, Jaaskelainen S, et al, Sensory dysfunction in burning mouth syndrome. Pain 99(1-2):41-7, September 2002.
   PubMedGoogle Scholar
• Jaaskelainen SK, Rinne JO, et al, Role of the dopaminergic system in chronic pain— a fluorodopa-PET study. Pain 90(3):257-60, Feb. 15, 2001.
   PubMedGoogle Scholar
• Hagelberg N, Forssell H, et al, Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 101(1-2):149-54, January 2003.
   PubMed Web of Science ®Google Scholar
• Hagelberg N, Martikainen IK, et al, Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99:273-9, 2002.
   PubMed Web of Science ®Google Scholar
• Zakrzewska JM, Forssell H, Glenny AM, Interventions for the treatment of burning mouth syndrome: A systematic review. J Orofac Pain 17(4):293-300, Fall 2003.
   PubMedGoogle Scholar
• Bergdahl J, Anneroth G, Perris H, Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: A controlled study. J Oral Pathol Med 24(5):213-5, May 1995.
   PubMedGoogle Scholar
• Femiano F, Gombos F, Scully C, Burning mouth syndrome: Open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 9(1):8-13, January-February 2004.
   PubMedGoogle Scholar
• Ehrnrooth E, Grau C, et al, Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer. Acta Oncol 40(6):745-50, 2001.
   PubMed Web of Science ®Google Scholar
• Woda A, Navez ML, et al, A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain 12(4):272-8, Fall 1998.
   PubMedGoogle Scholar
• Tammiala-Salonen T, Forssell H, Trazodone in burning mouth pain: A placebo-controlled, double-blind study. J Orofac Pain 13(2):83-8, Spring 1999.
   PubMedGoogle Scholar
• Gick CL, Mirowski GW, et al, Treatment of glossodynia with olanzapine. J Am Acad Dermatol 51(3):463-5, September 2004.
   PubMedGoogle Scholar
• Grushka M, Epstein J, Mott A, An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86(5):557-61, November 1998.
   PubMedGoogle Scholar
• Gremeau-Richard C, Woda A, et al, Topical clonazepam in stomatodynia: A randomized placebo-controlled study. Pain 108(1-2):51-7, March 2004.
   PubMedGoogle Scholar
• Scheinfeld N, The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol 42(6):491-5, June 2003.
   PubMedGoogle Scholar
• White TL, Kent PF, et al, Effectiveness of gabapentin for treatment of burning mouth syndrome. Arch Otolaryngol Head Neck Surg 130(6):786-8, June 2004.
   PubMedGoogle Scholar
• Ziegler D, Hanefeld M, et al, Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A seven-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-lipoic acid in diabetic neuropathy. Diabetes Care 22(8):1296-301, August 1999.
   PubMed Web of Science ®Google Scholar
• Femiano F, Scully C, Burning mouth syndrome (BMS): Double-blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 31(5):267-9, May 2002.
   PubMedGoogle Scholar
• Maina G, Vitalucci A, et al, Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: A single-blind study. J Clin Psychiatry 63(1):38-43, January 2002.
   PubMedGoogle Scholar
• Schoemaker H, Claustre Y, et al, Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280(1):83-97, January 1997.
   PubMed Web of Science ®Google Scholar